Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

CMS Announces Timeline for Drug Negotiations

From the College  |  January 20, 2023

A significant provision in the Inflation Reduction Act allows the Centers for Medicare & Medicaid Services (CMS) to negotiate drug pricing. Earlier this month, the CMS released the initial timeline for the development of this negotiation process.

This winter and spring, the CMS will outline key elements needed for negotiation, including the data collection sources and methodologies used to apply maximum fair prices. The CMS will seek public comments on these elements.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

By Sept. 1, 2023, the CMS will release the list of the 10 drugs that will be up for negotiation for the initial price applicability year. The negotiation process will begin in fall 2023 and continue until summer 2024, after which the CMS will publish the maximum fair prices for the 10 selected drugs. The new prices will become effective on Jan. 1, 2026. The negotiation process will occur annually, with additional medications selected for each cycle.

The ACR looks forward to actively participating in all public comment opportunities during this process.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Share: 

Filed under:Legislation & Advocacy Tagged with:ACR advocacyCenters for Medicare & Medicaid Services (CMS)drug price negotiation

Related Articles

    2023 Medicare Physician Fee Schedule Final Rule for Quality Payment Program Published

    January 6, 2023

    The ACR highlights essential policy and reporting changes to the Quality Payment Program for performance year 2023 and beyond. Key changes include policies regarding the development of new MIPS Value Pathways and refinement of subgroup participation.

    What’s in the New Biden Plan to Reduce U.S. Drug Prices?

    November 4, 2021

    WASHINGTON (Reuters)—U.S. President Joe Biden and his fellow Democrats promised voters sweeping drug price reform in their signature social spending bill but agreed to move ahead with a far less ambitious proposal after facing opposition in Congress. The plan could still fail as hurdles remain to approving the broader spending package, known as “Build Back…

    How to Navigate the Employment Offer

    September 6, 2022

    There’s nothing quite as exciting as answering a phone call to hear the words: “You’re hired.” After hours of research and preparation, multiple interviews and a healthy dose of daydreaming about your first day, you’ve made it across the finish line. Except for one final hurdle—the negotiation process. Don’t overlook it. The negotiation process is…

    How the U.S. Will Set Up New Medicare Drug Price Talks

    September 6, 2022

    WASHINGTON—The U.S. government will soon begin hiring experts and collecting the data needed to launch direct negotiations over prescription drug prices for older and disabled people, a top Biden administration official told Reuters. President Joe Biden last week signed into law the Inflation Reduction Act, introducing new policies to tackle climate change, taxes and the…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences